Related Experiment Videos

Potential roles of antisense technology in cancer chemotherapy

S T Crooke1

  • 1Isis Pharmaceuticals, Inc, Carlsbad, California 92008, USA.

Oncogene
|June 28, 2001
PubMed

Insights

Antisense technology shows promise for cancer chemotherapy, offering a valuable tool for gene functionalization and target validation. Emerging data suggest antisense drugs are safe and effective in preclinical and clinical cancer studies.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Oncology

Background:

  • Antisense technology utilizes nucleic acid molecules to modulate gene expression.
  • It has emerged as a significant tool in molecular biology and drug development.
  • Its application in cancer treatment is a rapidly evolving field.

Purpose of the Study:

  • To review the advancements in antisense technology for cancer chemotherapy.
  • To discuss the current landscape of anticancer antisense drugs in development.
  • To explore the future potential of antisense technology in oncology.

Main Methods:

  • Review of existing literature on antisense technology and its applications in cancer.
  • Analysis of preclinical and clinical data for antisense-based cancer therapies.
  • Discussion of gene functionalization and target validation using antisense approaches.

Main Results:

  • Antisense technology is a valuable tool for gene functionalization and target validation in cancer research.
  • Substantial evidence indicates the safety of antisense drugs.
  • Growing data demonstrate activity in animal cancer models and suggest efficacy in human cancer patients.

Conclusions:

  • Antisense technology holds significant potential for the future of cancer chemotherapy.
  • Continued research and development are crucial for realizing its full therapeutic benefits.
  • Antisense drugs represent a promising class of therapeutics for various cancers.

Related Concept Videos